CanBas Co Ltd ^None

CanBas Co Ltd is a biopharmaceutical company based in Japan that specializes in researching and developing anti-cancer drugs. They have developed CBP501 and CBS9106, which are currently in clinical trials for the treatment of various cancers, including malignant pleural mesothelioma and non-small cell lung cancers. The company was founded in 2000.